Ligand Pharmaceuticals | LGND - Pe Kurs-Gewinn

Aktienkurs
209.52
Täglich Wechseln
-1.47 -0.70%
Monatlich
12.45%
Jährlich
93.95%
Q1 Prognose
196.78




Pe Veränderung Datum
Amgen 25.31 15.82 2025-12
Anika Therapeutics 47.54 27.2 2024-06
Baxter International 17.1 4.46 2025-09
Bristol-Myers Squibb 9.28 1.04 2025-12
Eli Lilly 40.21 9.66 2025-12
Enviri Corporation 121.21 92.59 2023-06
Gilead Sciences 15.63 0.08 2025-12
GlaxoSmithKline 11.15 0.29 2025-12
Glaxosmithkline 11.93 6.46 2025-09
Heron Therapeutics 6.46 3.23 2006-12
Intrexon 7.54 221.44 2021-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Ligand Pharmaceuticals 60.65 17.62 2025-09
Merck 13.92 5.08 2025-12
Pacira 52.68 23.44 2025-12
Pfizer 14.48 5.18 2025-12
Rigel Pharmaceuticals 8.61 8.4 2025-03
Veracyte 45.3 5.4 2025-12